Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.49 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.48 |
| ▸ | SRD5A1 | P18405 | 5/20 | 0.48 |
| ▸ | SRD5A2 | P31213 | 5/20 | 0.48 |
| ▸ | CNR2 | P34972 | 10/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8959655 | 0.95 | SRD5A1 (0.49) | CNR1CREBBPSRD5A1SRD5A2CNR2 | |
| SCHEMBL8959858 | 0.91 | SRD5A1 (0.58) | CNR1CREBBPSRD5A1SRD5A2CNR2 | |
| SCHEMBL8959660 | 0.88 | SRD5A1 (0.43) | CNR1CREBBPSRD5A1SRD5A2 | |
| SCHEMBL8959720 | 0.87 | CNR1 (0.51) | CNR1CREBBPSRD5A1SRD5A2CNR2 | |
| SCHEMBL8959893 | 0.86 | CNR1 (0.50) | CNR1CREBBPSRD5A1SRD5A2CNR2 | |
| SCHEMBL8959973 | 0.86 | SRD5A1 (0.59) | CNR1SRD5A1SRD5A2CNR2 | |
| SCHEMBL9337367 | 0.84 | SRD5A1 (0.66) | CNR1CREBBPSRD5A1SRD5A2CNR2 | |
| SCHEMBL8959531 | 0.83 | CNR1 (0.50) | CNR1CREBBPSRD5A1SRD5A2CNR2 | |
| SCHEMBL8959704 | 0.82 | CNR1 (0.56) | CNR1CREBBPSRD5A1SRD5A2CNR2 | |
| SCHEMBL9337492 | 0.82 | SRD5A1 (0.65) | CNR1CREBBPSRD5A1SRD5A2CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5530019-A | FOR TREATMENT OF PROSTATE GLAND DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |